Terms: = Liver cancer AND ATP2B3, PMCA3, 492, ENSG00000067842 AND Prognosis
32 results:
1. Prognostic value of circulating tumor cells associated with white blood cells in solid cancer: a systematic review and meta-analysis of 1471 patients with solid tumors.
Ju M; Gao Z; Gu G; Huang H; Sun A; Zheng C; Li H; Zhang Y; Li K
BMC Cancer; 2023 Dec; 23(1):1224. PubMed ID: 38087278
[TBL] [Abstract] [Full Text] [Related]
2. Cuproptosis-related molecular patterns and gene (ATP7A) in hepatocellular carcinoma and their relationships with tumor immune microenvironment and clinical features.
Li S; Weng J; Xiao C; Lu J; Cao W; Song F; He Z; Zhang P; Zhu Z; Xu J
Cancer Rep (Hoboken); 2023 Dec; 6(12):e1904. PubMed ID: 37885090
[TBL] [Abstract] [Full Text] [Related]
3. A nationwide study on the current treatment status and natural prognosis of hepatocellular carcinoma in elderly.
Yoo JJ; Lee J; Choi GH; Lee MW; Park DA
Sci Rep; 2023 Sep; 13(1):14584. PubMed ID: 37666940
[TBL] [Abstract] [Full Text] [Related]
4. Preoperative systemic inflammatory response index predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation.
Cui S; Cao S; Chen Q; He Q; Lang R
Front Immunol; 2023; 14():1118053. PubMed ID: 37051235
[TBL] [Abstract] [Full Text] [Related]
5. Seven centimeters as an optimal cutoff value for prognosis stratification in large monofocal hepatocellular carcinoma.
Yen YH; Li WF; Kee KM; Wang CC; Cheng YF; Lu SN; Hung CH; Liu YW; Hu TH
Langenbecks Arch Surg; 2023 Jan; 408(1):12. PubMed ID: 36609929
[TBL] [Abstract] [Full Text] [Related]
6. Elevation of circulating TNF receptor 2 in cancer: A systematic meta-analysis for its potential as a diagnostic cancer biomarker.
Kartikasari AER; Cassar E; Razqan MAM; Szydzik C; Huertas CS; Mitchell A; Plebanski M
Front Immunol; 2022; 13():918254. PubMed ID: 36466914
[TBL] [Abstract] [Full Text] [Related]
7. Impairment of perioperative activities of daily living is associated with poor prognosis following hepatectomy for hepatocellular carcinoma.
Mima K; Imai K; Kaida T; Matsumoto T; Nakagawa S; Sawayama H; Hayashi H; Yamashita YI; Baba H
J Surg Oncol; 2022 Nov; 126(6):995-1002. PubMed ID: 35796726
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic potential of the small GTPase Ran and its methylation in hepatocellular carcinoma.
Liu HH; Wang J; Zhang Y; Fan YC; Wang K
Hepatobiliary Pancreat Dis Int; 2022 Jun; 21(3):248-256. PubMed ID: 35367146
[TBL] [Abstract] [Full Text] [Related]
9. Baseline HBV-DNA load plus AST/ALT ratio predicts prognosis of HBV-related hepatocellular carcinoma after hepatectomy: A multicentre study.
Shen J; Dai J; Zhang Y; Xie F; Yu Y; Li C; Wen T
J Viral Hepat; 2021 Nov; 28(11):1587-1596. PubMed ID: 34464991
[TBL] [Abstract] [Full Text] [Related]
10. Hepatic dysfunction impairs prognosis in critically ill patients with hematological malignancies: A post-hoc analysis of a prospective multicenter multinational dataset.
Bisbal M; Darmon M; Saillard C; Mallet V; Mouliade C; Lemiale V; Benoit D; Pene F; Kouatchet A; Demoule A; Vincent F; Nyunga M; Bruneel F; Lebert C; Renault A; Meert AP; Hamidfar R; Jourdain M; Azoulay E; Mokart D
J Crit Care; 2021 Apr; 62():88-93. PubMed ID: 33310587
[TBL] [Abstract] [Full Text] [Related]
11. Novel Value of Preoperative Gamma-Glutamyltransferase Levels in the prognosis of AFP-Negative Hepatocellular Carcinoma.
Lu LH; Wei-Wei ; Kan A; Jie-Mei ; Ling YH; Li SH; Guo RP
Dis Markers; 2020; 2020():4269460. PubMed ID: 32695241
[TBL] [Abstract] [Full Text] [Related]
12. Hypernatremia at admission predicts poor survival in patients with terminal cancer: a retrospective cohort study.
Seo MS; Hwang IC; Jung J; Lee H; Choi JH; Shim JY
BMC Palliat Care; 2020 Jul; 19(1):94. PubMed ID: 32611346
[TBL] [Abstract] [Full Text] [Related]
13. Hepatic resection versus transarterial chemoembolization in infiltrative hepatocellular carcinoma: A multicenter study.
Wang Y; Shen J; Feng S; Liang R; Lai J; Li D; Peng B; Wang Z; Huang C; Kuang M
J Gastroenterol Hepatol; 2020 Dec; 35(12):2220-2228. PubMed ID: 32246889
[TBL] [Abstract] [Full Text] [Related]
14. Impact of histotypes on preferential organ-specific metastasis in triple-negative breast cancer.
Li Y; Su P; Wang Y; Zhang H; Liang Y; Zhang N; Song X; Li X; Li J; Yang Q
Cancer Med; 2020 Feb; 9(3):872-881. PubMed ID: 31814295
[TBL] [Abstract] [Full Text] [Related]
15. The Significance of Sidedness in Patients with Metastatic Colorectal cancer Treated with Triplet First-line Chemotherapy.
Bazarbashi S; Omar AT; Raddaoui L; Badran A; Alzahrani A; Aljubran A; Elhassan T
Asian Pac J Cancer Prev; 2019 Oct; 20(10):2891-2896. PubMed ID: 31653131
[TBL] [Abstract] [Full Text] [Related]
16. Salvage treatment for recurrences after first resection of colorectal liver metastases: the impact of histopathological growth patterns.
Nierop PMH; Galjart B; Höppener DJ; van der Stok EP; Coebergh van den Braak RRJ; Vermeulen PB; Grünhagen DJ; Verhoef C
Clin Exp Metastasis; 2019 Apr; 36(2):109-118. PubMed ID: 30843120
[TBL] [Abstract] [Full Text] [Related]
17. The Immunoscore system predicts prognosis after liver metastasectomy in colorectal cancer liver metastases.
Wang Y; Lin HC; Huang MY; Shao Q; Wang ZQ; Wang FH; Yuan YF; Li BK; Wang DS; Ding PR; Chen G; Wu XJ; Lu ZH; Li LR; Pan ZZ; Sun P; Yan SM; Wan DS; Xu RH; Li YH
Cancer Immunol Immunother; 2018 Mar; 67(3):435-444. PubMed ID: 29204700
[TBL] [Abstract] [Full Text] [Related]
18. Thymidylate synthase gene polymorphisms as important contributors affecting hepatocellular carcinoma prognosis.
Wang X; Sun X; Du X; Zhou F; Yang F; Xing J; Dong G; Guo X
Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):319-326. PubMed ID: 28043790
[TBL] [Abstract] [Full Text] [Related]
19. Mortality in hepatitis C patients who achieve a sustained viral response compared to the general population.
Innes H; McDonald S; Hayes P; Dillon JF; Allen S; Goldberg D; Mills PR; Barclay ST; Wilks D; Valerio H; Fox R; Bhattacharyya D; Kennedy N; Morris J; Fraser A; Stanley A; Bramley P; Hutchinson SJ
J Hepatol; 2017 Jan; 66(1):19-27. PubMed ID: 27545496
[TBL] [Abstract] [Full Text] [Related]
20. Genetic variants in glucose-6-phosphate isomerase gene as prognosis predictors in hepatocellular carcinoma.
Lyu Z; Chen Y; Guo X; Zhou F; Yan Z; Xing J; An J; Zhang H
Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):698-704. PubMed ID: 27288297
[TBL] [Abstract] [Full Text] [Related]
[Next]
